14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Friday, 3rd May 2024 FARN.L stock ended at £153.00. This is 2.00% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.94% from a day low at £147.20 to a day high of £153.00.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Faron Pharmaceuticals Oy prices

Date Open High Low Close Volume
May 03, 2024 £153.00 £153.00 £147.20 £153.00 8 165
May 02, 2024 £145.00 £154.00 £145.00 £150.00 4 213
May 01, 2024 £145.00 £150.00 £145.00 £150.00 1 910
Apr 30, 2024 £144.50 £152.50 £132.00 £145.00 21 598
Apr 29, 2024 £135.00 £146.00 £134.75 £140.00 25 094
Apr 26, 2024 £135.00 £135.00 £125.60 £127.50 1 513
Apr 25, 2024 £121.50 £132.75 £121.50 £132.75 195
Apr 24, 2024 £120.00 £129.00 £120.00 £127.50 22 023
Apr 23, 2024 £117.55 £120.15 £117.55 £120.15 1 464
Apr 22, 2024 £117.50 £117.50 £117.50 £117.50 0
Apr 19, 2024 £115.11 £118.30 £113.00 £117.50 4 573
Apr 18, 2024 £120.00 £125.00 £115.00 £118.00 51 043
Apr 17, 2024 £123.50 £128.83 £120.00 £120.00 38 847
Apr 16, 2024 £128.65 £130.00 £125.00 £128.90 11 789
Apr 15, 2024 £123.67 £132.50 £120.00 £125.00 16 607
Apr 12, 2024 £135.00 £135.00 £120.00 £134.00 30 838
Apr 11, 2024 £135.00 £135.00 £120.00 £127.50 46
Apr 10, 2024 £137.90 £137.90 £120.00 £127.50 38 466
Apr 09, 2024 £125.00 £140.00 £125.00 £138.80 7 011
Apr 08, 2024 £139.25 £139.25 £125.00 £129.55 4 039
Apr 05, 2024 £137.00 £139.25 £126.25 £132.50 49 507
Apr 04, 2024 £137.00 £145.00 £120.00 £138.00 19 679
Apr 03, 2024 £150.00 £150.00 £138.00 £150.00 12 116
Apr 02, 2024 £137.50 £137.50 £137.50 £137.50 0
Mar 28, 2024 £135.00 £145.00 £130.00 £137.50 40 251
Click to get the best stock tips daily for free!

About Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, car... FARN.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT